Seema Mudhol

Dr. Seema Mudhol

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SMSeema Mudhol
Seema Mudhol
Muthukumar Serva PeddhaMuthukumar Serva Peddha
Muthukumar Serva Peddha

23 November 2023 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
MKMohammed Touseef Khan
Mohammed Touseef Khan
SMSeema Mudhol
Seema Mudhol
VMVallamkondu Manasa
Vallamkondu Manasa
Muthukumar Serva PeddhaMuthukumar Serva Peddha
Muthukumar Serva Peddha
KKKrupashree Krishnaswamy
Krupashree Krishnaswamy


22 July 2025 in Gels
Verified
Journal Article
Open access
PDF file
BBBushra Begum
Bushra Begum
SMSeema Mudhol
Seema Mudhol
BBBaseera Begum
Baseera Begum
SMSyeda Noor Madni
Syeda Noor Madni
SPSharath Honganoor Padmanabha
Sharath Honganoor Padmanabha
NGN Vishal Gupta
N Vishal Gupta
Background and Objective: Intervertebral disc degeneration (IVDD) is a leading cause of lower back pain with limited regenerative treatments. Among emerging regenerative approaches, growth factor-based therapies, such as recombinant human transforming growth factor-beta (Rh-TGF-β), have shown potential for disc regeneration but are hindered by rapid degradation and uncontrolled release by direct administration. Additionally, mechanical stress elevates heat shock protein 90 (HSP-90), impairing cell function and extracellular matrix (ECM) production. This study aimed to investigate a dual self-cross-linked alginate di-aldehyde (ADA) hydrogel system for the sustained delivery of Rh-TGF-β and epigallocatechin gallate (EGCG) to enhance protein stability, regulate release, and promote disc regeneration by targeting both regenerative and stress-response pathways. Methods: ELISA and UV-Vis spectrophotometry assessed Rh-TGF-β and EGCG release profiles. A rat tail IVDD model was established with an Ilizarov-type external fixator for loading, followed by hydrogel treatment with or without bioactive agents. Disc height, tissue structure, and protein expression were evaluated via radiography, histological staining, immunohistochemistry, and Western blotting. Results: The hydrogel demonstrated a biphasic release profile with 100% Rh-TGF-β released over 60 days and complete EGCG release achieved within 15 days. Treated groups showed improved disc height, structural integrity, and proteoglycan retention revealed by histological analysis and elevated HSP-90 expression by immunohistochemistry. In contrast, Western blot analysis confirmed that EGCG effectively downregulated HSP-90 expression, suggesting a reduction in mechanical stress-induced degeneration. Conclusions: ADA hydrogel effectively delivers therapeutic agents, offering a promising strategy for IVDD treatment.

18 August 2025 in Polymers for Advanced Technologies
Verified
Journal Article
Closed access
SMSeema Mudhol
Seema Mudhol
TVToragall Veeresh
Toragall Veeresh
Muthukumar Serva PeddhaMuthukumar Serva Peddha
Muthukumar Serva Peddha

30 September 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
RDR. Dhanush
R. Dhanush
DND. K. Naveen
D. K. Naveen
HSH. R. Sneha
H. R. Sneha
SMSeema Mudhol
Seema Mudhol
BRBharathi Doddla Raghunathanaidu
Bharathi Doddla Raghunathanaidu